SARAH COX: Open Payments
NPI 1598497489 · JEFFERSON CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,535 in 98 payments from 17 companies in 2025. Trend: 2023 $825 · 2024 $901 · 2025 $1,535
Food & beverage: $1,535
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 31 | $441 |
| ABBVIE INC. | 18 | $287 |
| Novo Nordisk Inc | 12 | $141 |
| Dexcom, Inc. | 5 | $118 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $64 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| Lilly USA, LLC | 4 | $59 |
| Phathom Pharmaceuticals, Inc. | 4 | $48 |
| Axsome Therapeutics, Inc. | 3 | $46 |
Products named: NURTEC ODT, UBRELVY, Dexcom G6 Transmitter, Wegovy, QULIPTA, PREVNAR 20, ELIQUIS, JOURNAVX.
Industry payments across MO — which companies pay providers there.
